What does CUSIP 09077B104 represent in this 13F holders report?

CUSIP 09077B104 is the security identifier for BCAB - BioAtla, Inc. - Common Stocks, par value $0,0001 per share used to aggregate holder disclosures.

How many institutions held BCAB - BioAtla, Inc. - Common Stocks, par value $0,0001 per share in Q4 2020?

53 institutional investors reported BCAB - BioAtla, Inc. - Common Stocks, par value $0,0001 per share for Q4 2020. Use the holders table for investor-level position and value details.

BioAtla, Inc. - Common Stocks, par value $0,0001 per share (BCAB)

CUSIP: 09077B104

Q4 2020 13F Holders as of 31 Dec 2020

Type / Class: Equity / Common Stocks, par value $0,0001 per share
Shares outstanding: 58,548,563
Total 13F shares: 15,664,281
Share change: +15,664,281
Total reported value: $530,219,000
Price per share: $34.01
Number of holders: 53
Value change: +$530,219,000
Number of buys: 53

Quarterly Holders Quick Answers

What is CUSIP 09077B104?
CUSIP 09077B104 identifies BCAB - BioAtla, Inc. - Common Stocks, par value $0,0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2021

Recent filing periods for CUSIP 09077B104:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of BCAB - BioAtla, Inc. - Common Stocks, par value $0,0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.

Institutional Holders of BioAtla, Inc. - Common Stocks, par value $0,0001 per share (BCAB) as of Q4 2020

As of 31 Dec 2020, BioAtla, Inc. - Common Stocks, par value $0,0001 per share (BCAB) was held by 53 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 15,664,281 shares. The largest 10 holders included Soleus Capital Management, L.P., Cormorant Asset Management, LP, FARALLON CAPITAL MANAGEMENT LLC, FMR LLC, JANUS HENDERSON GROUP PLC, BAKER BROS. ADVISORS LP, BOXER CAPITAL, LLC, PRICE T ROWE ASSOCIATES INC /MD/, WELLINGTON MANAGEMENT GROUP LLP, and MASSACHUSETTS FINANCIAL SERVICES CO /MA/. This page lists 53 institutional shareholders reporting positions in this security for the Q4 2020 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2020 vs Q4 2025 Across Filers

Q4 2025 holders

Q4 2020 holders

Holder diff

Investor	Q4 2025 Shares	Q4 2020 Shares	Share Diff	Share Chg %	Q4 2025 Value $	Q4 2020 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.